Open access · OA
via OpenAlex
ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice
Safak Yalcin, Dragan Marinković, Sathish Kumar Mungamuri, Xin Zhang, Wei Tong, Rani S. Sellers, Saghi Ghaffari
The EMBO Journal · 2010 · ▲ 143 citations
Abstract
This 2010 study in The EMBO Journal examines the role of ROS-mediated AKT/mTOR(definition) signaling in the development of myeloproliferative syndrome in Foxo3 mice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/emboj.2010.292
- Canonical
- link ↗
- Fetched
- 2026-08-27 MST
Cite this
APA
Yalcin, S., Marinković, D., Mungamuri, S.K., Zhang, X., Tong, W., Sellers, R.S., & Ghaffari, S. (2010). ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice. <em>The EMBO Journal</em>. https://doi.org/10.1038/emboj.2010.292
Vancouver
Yalcin S, Marinković D, Mungamuri SK, Zhang X, Tong W, Sellers RS, et al. ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice. The EMBO Journal. 2010. doi:10.1038/emboj.2010.292.
BibTeX
@article{safak2010ROSmed,
title = {ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice},
author = {Safak Yalcin and Dragan Marinković and Sathish Kumar Mungamuri and Xin Zhang and Wei Tong and Rani S. Sellers and Saghi Ghaffari},
journal = {The EMBO Journal},
year = {2010},
doi = {10.1038/emboj.2010.292},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Research Square 2026
Preprint · CC-BY
Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance
AGE 2013
Open access · OA
Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025
Citation only
Apigenin enhancing oxidative resistance and proteostasis to extend lifespan via PTEN-mediated AKT signalling pathway
Clinical and translational medicine 2026
Open access · OA
SelO-mediated nicotinamide adenine dinucleotide hydrolysis and its implications for metabolic therapies.
Innovation in aging 2025
Open access · OA
Targeting Vascular Aging in Progeria by mTOR Inhibitors from Multi-Omics Screening
Frontiers in Pharmacology 2016
Open access · CC-BY